Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases
- PMID: 14981167
- DOI: 10.1212/wnl.62.4.538
Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases
Abstract
The caveolin-3 protein is expressed exclusively in muscle cells. Caveolin-3 expression is sufficient to form caveolae-sarcolemmal invaginations that are 50 to 100 nm in diameter. Monomers of caveolin-3 oligomerize to form high molecular mass scaffolding on the cytoplasmic surface of the sarcolemmal membrane. A mutation in one caveolin-3 allele produces an aberrant protein product capable of sequestering the normal caveolin-3 protein in the Golgi apparatus of skeletal muscle cells. Improper caveolin-3 oligomerization and membrane localization result in skeletal muscle T-tubule system derangement, sarcolemmal membrane alterations, and large subsarcolemmal vesicle formation. To date, there have been eight autosomal dominant caveolin-3 mutations identified in the human population. Caveolin-3 mutations can result in four distinct, sometimes overlapping, muscle disease phenotypes: limb girdle muscular dystrophy, rippling muscle disease, distal myopathy, and hyperCKemia. Thus, the caveolin-3 mutant genotype-to-phenotype relation represents a clear example of how genetic background can influence phenotypic outcome. This review examines in detail the reported cases of patients with caveolin-3 mutations and their corresponding muscle disease phenotypes.
Similar articles
-
Caveolinopathies: from the biology of caveolin-3 to human diseases.Eur J Hum Genet. 2010 Feb;18(2):137-45. doi: 10.1038/ejhg.2009.103. Epub 2009 Jul 8. Eur J Hum Genet. 2010. PMID: 19584897 Free PMC article. Review.
-
Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.Am J Physiol Cell Physiol. 2003 Nov;285(5):C1150-60. doi: 10.1152/ajpcell.00166.2003. Epub 2003 Jul 2. Am J Physiol Cell Physiol. 2003. PMID: 12839838
-
A CAV3 microdeletion differentially affects skeletal muscle and myocardium.Neurology. 2003 Dec 9;61(11):1513-9. doi: 10.1212/01.wnl.0000097320.35982.03. Neurology. 2003. PMID: 14663034
-
Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.Nat Genet. 2001 Jul;28(3):218-9. doi: 10.1038/90050. Nat Genet. 2001. PMID: 11431690
-
Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.Handb Clin Neurol. 2011;101:135-42. doi: 10.1016/B978-0-08-045031-5.00010-4. Handb Clin Neurol. 2011. PMID: 21496630 Review.
Cited by
-
Defective interactions of protein partner with ion channels and transporters as alternative mechanisms of membrane channelopathies.Biochim Biophys Acta. 2014 Feb;1838(2):723-30. doi: 10.1016/j.bbamem.2013.05.024. Epub 2013 May 31. Biochim Biophys Acta. 2014. PMID: 23732236 Free PMC article. Review.
-
Coexistence of a Heterozygous Caveolin-3 Deletion and a Novel Dystrophin Gene Mutation in a Duchenne Muscular Dystrophy Patient.Cureus. 2023 Feb 6;15(2):e34704. doi: 10.7759/cureus.34704. eCollection 2023 Feb. Cureus. 2023. PMID: 36909082 Free PMC article.
-
[Limb girdle muscular dystrophies].Nervenarzt. 2004 Dec;75(12):1153-66. doi: 10.1007/s00115-004-1769-5. Nervenarzt. 2004. PMID: 15316618 Review. German.
-
Differential diagnosis of vacuolar myopathies in the NGS era.Brain Pathol. 2020 Sep;30(5):877-896. doi: 10.1111/bpa.12864. Epub 2020 Jun 15. Brain Pathol. 2020. PMID: 32419263 Free PMC article.
-
Caveolinopathies: from the biology of caveolin-3 to human diseases.Eur J Hum Genet. 2010 Feb;18(2):137-45. doi: 10.1038/ejhg.2009.103. Epub 2009 Jul 8. Eur J Hum Genet. 2010. PMID: 19584897 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
